Impact of Neutrophil Extracellular Traps on Clinical Outcome after Subarachnoid Hemorrhage: A Translational Narrative Review
Abstract
Aneurysmal subarachnoid hemorrhage (aSAH) remains associated with substantial morbidity and mortality despite best medical treatment. Increasing evidence implicates thrombo-inflammation (TI), driven by neutrophils and neutrophil extracellular traps (NETs), in the pathogenesis of delayed cerebral ischemia (DCI) and cognitive impairment. This narrative review summarizes experimental and clinical data linking neutrophil activation and NETs formation to DCI after aSAH and outlines emerging therapeutic strategies. This review was structured according to the SANRA (Scale for the Assessment of Narrative Review Articles) guidelines and followed general recommendations for narrative reviews. A comprehensive PubMed and clinicaltrials.gov search identified experimental and clinical studies published in English without time window, focusing on TI, neutrophil activation, or NETosis in the acute phase of aSAH. Past and ongoing clinical trials were classified by mechanism of action. Experimental models and human data show early and sustained neutrophil activation within cerebral and systemic compartments after aSAH. NETs promote microvascular thrombosis, blood-brain barrier disruption, microglial activation, and neuronal injury, ultimately contributing to DCI and long-term cognitive impairment. Outside the brain, NETs may also aggravate neurogenic pulmonary edema and cardiac dysfunction. In animal models, deoxyribonuclease I (DNase I) effectively degrades NETs, improving perfusion, limiting neuronal apoptosis, and enhancing recovery. Several ongoing trials target TI pathways, including the RESET trial, which evaluates the impact of IV DNase I on clinical outcome after aSAH. NETs produced after neutrophil activation may be central to DCI. Targeting NETs represents a promising translational path to improve cerebral and systemic outcomes after aSAH.
Related
- Immature neutrophil response is associated with cardiac complications after non-traumatic subarachnoid hemorrhage.
- Plant-derived extracellular vesicles in musculoskeletal disorders: a narrative review of mechanisms, therapeutic efficacy, and translational prospects
- Subarachnoid Hemorrhage Following Ischemic Stroke in Vertebrobasilar Dolichoectasia
- A Hemorrhagic Spinal Tumor Presenting as an Intracranial Subarachnoid Hemorrhage
- Do Early Prognostic Measures Differentiate Mechanisms of ICU Death in Aneurysmal Subarachnoid Hemorrhage? An Analysis of Fatal Outcomes
BibTeX
@article{delvoye2026impact,
title = {{Impact of Neutrophil Extracellular Traps on Clinical Outcome after Subarachnoid Hemorrhage: A Translational Narrative Review}},
author = {François Delvoye and Julie Lebeau and Cécile Oury and Céline D’emal and Bernard Lambermont and Nathalie Layios and Didier Ledoux and Annie Dubuisson and Louis Deprez and Martin Moïse and Benoît Ho-Tin-Noé and Mikaël Mazighi and Nicolas Engrand and Jean-Philippe Désilles and Benjamin Maïer},
journal = {Translational stroke research},
year = {2026},
month = jun,
doi = {10.1007/s12975-026-01461-6},
url = {https://hal.science/hal-05790374v1},
note = {CC BY},
}
RIS
TY - JOUR
TI - Impact of Neutrophil Extracellular Traps on Clinical Outcome after Subarachnoid Hemorrhage: A Translational Narrative Review
AU - François Delvoye
AU - Julie Lebeau
AU - Cécile Oury
AU - Céline D’emal
AU - Bernard Lambermont
AU - Nathalie Layios
AU - Didier Ledoux
AU - Annie Dubuisson
AU - Louis Deprez
AU - Martin Moïse
AU - Benoît Ho-Tin-Noé
AU - Mikaël Mazighi
AU - Nicolas Engrand
AU - Jean-Philippe Désilles
AU - Benjamin Maïer
PY - 2026
DA - 2026/06/30
JO - Translational stroke research
DO - 10.1007/s12975-026-01461-6
UR - https://hal.science/hal-05790374v1
AB - Aneurysmal subarachnoid hemorrhage (aSAH) remains associated with substantial morbidity and mortality despite best medical treatment. Increasing evidence implicates thrombo-inflammation (TI), driven by neutrophils and neutrophil extracellular traps (NETs), in the pathogenesis of delayed cerebral ischemia (DCI) and cognitive impairment. This narrative review summarizes experimental and clinical data linking neutrophil activation and NETs formation to DCI after aSAH and outlines emerging therapeutic strategies. This review was structured according to the SANRA (Scale for the Assessment of Narrative Review Articles) guidelines and followed general recommendations for narrative reviews. A comprehensive PubMed and clinicaltrials.gov search identified experimental and clinical studies published in English without time window, focusing on TI, neutrophil activation, or NETosis in the acute phase of aSAH. Past and ongoing clinical trials were classified by mechanism of action. Experimental models and human data show early and sustained neutrophil activation within cerebral and systemic compartments after aSAH. NETs promote microvascular thrombosis, blood-brain barrier disruption, microglial activation, and neuronal injury, ultimately contributing to DCI and long-term cognitive impairment. Outside the brain, NETs may also aggravate neurogenic pulmonary edema and cardiac dysfunction. In animal models, deoxyribonuclease I (DNase I) effectively degrades NETs, improving perfusion, limiting neuronal apoptosis, and enhancing recovery. Several ongoing trials target TI pathways, including the RESET trial, which evaluates the impact of IV DNase I on clinical outcome after aSAH. NETs produced after neutrophil activation may be central to DCI. Targeting NETs represents a promising translational path to improve cerebral and systemic outcomes after aSAH.
SN - 1868-4483
SN - 1868-601X
ER -